Handok and Pfizer Korea signed business agreement for co-promotion of osteoporosis treatment 'Viviant'

Handok and Pfizer Korea signed business agreement for co-promotion of osteoporosis treatment 'Viviant'. As a result, Pfizer Korea is responsible for sales and marketing of Viviant in general hospitals, and Handok is responsible for sales and marketing of Viviant in hospitals and clinics.

Pfizer Korea released 'Viviant' in 2012. Viviant (ingredient Bazedoxifene Acetate) is the selective estroge...